How Do I Know if a Stock Fits My Portfolio?
A good stock can be a bad addition. Here is how to measure what a new position would do to your correlation, concentration and crash exposure before you buy it, with real numbers.
ResourcesGuide
How Do I Evaluate a Stock Idea Before Buying?
A practical checklist for testing a stock idea: the thesis, the business, the price, what analysts with real track records say, how it behaved in crashes, and whether it fits the portfolio you already own.
Key takeaways
- Start from the base rate: over the 10 years to Sep 30, 2026, only 36.0% of today’s largest US stocks beat the S&P 500 in Exent’s data. Any single idea needs a reason to be in that minority.
- Test six things: a one-sentence thesis, the business, the price, what accurate analysts say, the crash history, and the fit with your portfolio.
- Portfolio fit is the step most investors skip. The same stock can diversify one portfolio and double the main risk of another.
- Decide the position size and what would prove you wrong before you buy, not after the price moves.
In this article
Why evaluate a stock idea at all?
Because most individual stocks do not beat the index. Exent compared today’s largest US-listed stocks with the S&P 500 index fund (SPY) over several periods to Sep 30, 2026:
| Period | Stocks measured | Beat the S&P 500 | Share that beat it |
|---|---|---|---|
| 1 year | 477 | 188 | 39.4% |
| 3 years | 477 | 178 | 37.3% |
| 5 years | 468 | 182 | 38.9% |
| 10 years | 422 | 152 | 36.0% |
That list starts from companies that are large today, so it is tilted toward winners; the true share is lower. Over a longer horizon, Hendrik Bessembinder’s 2018 study found that 4.3% of US stocks accounted for all the stock market’s wealth creation above Treasury bills from 1926 to 2016. A good evaluation process is mostly about avoiding the ideas that only look like winners. More in how many stocks beat the S&P 500.
Can I explain why it will work in one sentence?
If not, you do not have an idea yet, you have a ticker. A usable thesis names what the market is missing, what will make it visible (a catalyst), and what would prove it wrong. “Great company” is not a thesis; the price usually already says so. Our guide on how to write an investment thesis gives a template.
Is the business strong, and is the price reasonable?
Check the business first, then whether the price already assumes the good news. These are the questions analysts usually start with:
| Check | What to look at | Red flag |
|---|---|---|
| Growth | Revenue and earnings over several years | Growth bought with acquisitions or falling margins |
| Profitability | Gross and operating margins, return on capital | Margins shrinking while revenue grows |
| Cash | Free cash flow vs reported earnings | Earnings rising, cash flow not |
| Balance sheet | Debt vs cash flow, upcoming maturities | Debt that needs refinancing at higher rates |
| Valuation | P/E and forward P/E vs its own history and peers | Price that requires everything to go right |
| Dilution | Share count trend | Share count rising every year |
A low P/E ratio alone is not a bargain; it is often a warning. See value traps and free cash flow.
What do analysts with real track records say?
Look at who rates the stock, not just the average rating. The average call is close to a coin flip: in Exent’s 7-year backtest of 628,792 ratings (statistics as of Jun 24, 2026), price targets were reached 52.4% of the time. Analysts with a 5-star rating in that scoring reached a median 60.8% of theirs. Those star ratings are computed from the same past calls, so they describe history, not a guarantee.
Useful questions: do analysts with strong records on this sector agree? Are estimates being revised up or down? Is the consensus price target far above the price because of one outlier? The full study is in analyst accuracy, and individual records are on the analyst rankings.
How did the stock behave in past crashes?
Check its peak-to-trough fall in several different sell-offs and compare it with the index. A stock that falls twice as far as the market will test your patience in exactly the moments you are least patient. NVIDIA as an example, from our data:
| Sell-off | NVIDIA fall | S&P 500 fund (SPY) fall |
|---|---|---|
| Global financial crisis, 2007–09 | −85.1% | −56.5% |
| 2018 trade-war sell-off | −56.0% | −20.2% |
| COVID crash, 2020 | −37.6% | −34.1% |
| 2022 bear market | −61.8% | −25.4% |
| 2025 tariff sell-off | −32.7% | −19.0% |
NVIDIA also returned far more than the index over the decade, which is the point: a large potential reward came with deep, repeated falls. Knowing that before buying is what lets you size the position so you can hold it. Per-ticker crash data is on stock pages such as NVDA.
Does it fit the portfolio I already own?
Check what the stock does to your whole portfolio: its correlation with your largest holdings, the concentration after buying, and the crash exposure it adds. Two stocks, from our data over the five years to Sep 30, 2026:
| Measure | AMD | Exxon Mobil (XOM) |
|---|---|---|
| Correlation with the Nasdaq-100 fund (QQQ) | 0.71 | −0.13 |
| Fall in the 2022 bear market | −61.6% | −20.5% |
| S&P 500 fund volatility with 5% added (15.7% alone) | 17.1% | 15.1% |
Neither is the better stock on this table; they do different jobs. For a portfolio already heavy in a Nasdaq-100 fund and chip stocks, AMD adds more of the same engine; Exxon adds a different one. For a portfolio of energy and utilities, the logic flips. The full method, with a worked example, is in does this stock fit my portfolio.
The full stock idea checklist
- Thesis: one sentence on what the market is missing, the catalyst, and what would prove it wrong.
- Business: growth, margins and free cash flow moving in the same direction.
- Balance sheet: debt the company can carry through a bad year.
- Price: valuation compared with its own history and peers, not just a low P/E.
- Analysts: what the ones with strong records on this sector say, and which way estimates are moving.
- Crash history: its fall in at least three different sell-offs, compared with the index.
- Portfolio fit: correlation with your largest holdings, the new concentration, and the crash exposure it adds.
- Size and exit: the weight you will start at, the maximum you will let it reach, and the evidence that would make you sell.
The last three checks are easiest on your real holdings, with a portfolio analysis: correlation clusters, concentration and crash replays.
How to check an idea with Exent
- Stocks Radar shows each stock’s analyst ratings and price targets, with analysts ranked by past accuracy.
- Gems flag stocks where several top‑rated analysts (4★ and above) agree: Exent’s hunt for the next big winners, not a promise.
- Upload your holdings and add the idea in the what‑if simulator to see its effect on correlation clusters, concentration and crash replays.
Frequently asked questions
A clear thesis, the business and balance sheet, the valuation, what analysts with strong track records say, how the stock behaved in past crashes, and how it changes your portfolio’s correlation, concentration and crash exposure.
Compare valuation measures like P/E and price to free cash flow with the company’s own history and its peers, and ask what growth the price assumes. A low multiple can also signal a shrinking business, so check the trend in margins and cash flow.
Partly. The average rating is close to a coin flip: in Exent’s 7-year backtest, price targets were reached 52.4% of the time. Ratings from analysts with strong records on the sector carry more information than the average.
In Exent’s data, 36.0% of today’s largest US stocks beat the S&P 500 over the 10 years to September 30, 2026, and the list is tilted toward survivors. Most individual stocks lag the index.
There is no single right number. A common approach is to size each idea so its worst historical fall would be a loss you could live with, and to treat stocks that move together as one position.
See what your portfolio is really made of.
Upload a screenshot of your holdings and get concentration, overlap, crash exposure and a risk-matched benchmark in about a minute.
Check my portfolioLimited offer$1.95 for unlimited checks· unlimited checks
Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.